rs139521179
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_144988.4(ALG14):c.113G>T(p.Ser38Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00307 in 1,614,186 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_144988.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALG14 | NM_144988.4 | c.113G>T | p.Ser38Ile | missense_variant | 1/4 | ENST00000370205.6 | NP_659425.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALG14 | ENST00000370205.6 | c.113G>T | p.Ser38Ile | missense_variant | 1/4 | 1 | NM_144988.4 | ENSP00000359224 | P1 | |
ALG14 | ENST00000495856.1 | n.89G>T | non_coding_transcript_exon_variant | 1/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00223 AC: 340AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00194 AC: 487AN: 251352Hom.: 1 AF XY: 0.00200 AC XY: 272AN XY: 135868
GnomAD4 exome AF: 0.00316 AC: 4621AN: 1461878Hom.: 7 Cov.: 31 AF XY: 0.00313 AC XY: 2279AN XY: 727238
GnomAD4 genome AF: 0.00223 AC: 340AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.00173 AC XY: 129AN XY: 74474
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 08, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 22, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | ALG14: BP4, BS2 - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 15, 2019 | - - |
Congenital myasthenic syndrome 15 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
ALG14-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 11, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at